{"url_path":"/sec/lmed/8-k/2026-05-08/item-5-03","section_key":"item-5-03","section_title":"Item 5.03 — AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1477960/0001477932-26-002848-index.html","accession_number":"0001477932-26-002848","cik":"0001477960","ticker":"LMED","issuer_name":"LataMed AI Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1477960/0001477932-26-002848-index.html","primary_entity_key":"0001477960","primary_entity_name":"LataMed AI Corp."},"word_count":396,"has_tables":true,"body_markdown":"**ITEM 5.03 — AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS.**\n\n \n\nOn May 6, 2026, the Board of Directors of LataMed AI Corp. (formerly Catalyst Crew Technologies Corp.) (the “Company”) approved the designation of a new series of preferred stock designated as the “Series C Voting Preferred Stock” and filed a Certificate of Designation with the Nevada Secretary of State establishing the rights, preferences, and limitations of such series.\n\n \n\nThe principal terms of the Series C Voting Preferred Stock include, among other things:\n\n \n\n \n\n·\n\nAuthorized Shares: 5,000,000\n\n \n\n·\n\nVoting Rights: Each share is entitled to twenty (20) votes per share and votes together with the Company’s common stock as a single class on all matters submitted to stockholders\n\n \n\n·\n\nConversion: Non-convertible\n\n \n\n·\n\nDividend Rights: Dividends, if any, when and as declared by the Board of Directors, subject to the prior rights of any senior securities\n\n \n\n·\n\nLiquidation Preference: Senior to Common Stock; pari passu with any other series of Preferred Stock, unless expressly designated otherwise\n\n \n\n·\n\nRedemption: Non-redeemable\n\n \n\n·\n\nAdjustment: In the event the Company declares a stock dividend on Common Stock, effects a stock split, or recapitalizes the outstanding Common Stock, the Company shall simultaneously effect a proportional adjustment to the number of outstanding shares of Series C Preferred Stock\n\n \n\n·\n\nProtective Provisions: So long as any shares of Series C Preferred Stock are issued and outstanding, the Company shall not, without the approval of holders of a majority of the outstanding shares of Series C Preferred Stock: (a) create or issue any class or series of capital stock ranking senior to the Series C Preferred Stock; (b) amend or modify the terms of the Series C Preferred Stock in a manner that adversely affects the rights of such shares; (c) liquidate, dissolve, or wind up the business and affairs of the Company; or (d) take any action requiring class approval under applicable law\n\n \n\n·\n\nAssumption: Upon any consolidation, merger, reorganization, or similar transaction involving the Company, the surviving or successor entity shall assume all obligations, rights, and powers of the Company under the Certificate of Designation\n\n \n\nThe foregoing description of the Certificate of Designation does not purport to be complete and is qualified in its entirety by reference to the full text of the Certificate of Designation, which is filed as Exhibit 3.1 to this Current Report on Form 8-K and incorporated herein by reference."}